文献速递胃肠外科围术期管理与 ERAS

磁括约肌增强术与微创胃底折叠术短期安全性的比较:一项ACS-NSQIP分析

Short term safety of magnetic sphincter augmentation vs minimally invasive fundoplication: an ACS-NSQIP analysis.
PubMed 文献 · Surg Endosc · 2024-02-09

基于2017—2020年ACS-NSQIP数据库,比较磁括约肌增强术(MSA,n=597)与胃底折叠术(n=7285)的短期结局;MSA组再入院、并发症、手术时间和住院时间均更少,再手术与死亡率无显著差异;多因素分析显示MSA与并发症和再入院减少独立相关。

要点

  • MSA组并发症0.6% vs 胃底折叠术组4.0%,再入院2.2% vs 4.7%,均更少。
  • MSA组再手术1.0% vs 2.0%,死亡率0 vs 0.3%,两组无显著差异。
  • 多因素分析MSA与并发症减少(OR 0.23)和再入院减少(OR 0.53)独立相关。

核心结论

  • 在该全国数据库研究中,与胃底折叠术相比,MSA与术后并发症减少、再入院减少以及手术时间和住院时间缩短相关。
  • 作者指出,尽管MSA与胃底折叠术之间缺乏随机试验,机构和国家数据库研究继续支持将MSA作为一种安全的抗反流手术使用。

研究设计与样本

  • 利用2017—2020年美国外科医师学会国家外科质量改进计划(ACS-NSQIP)登记数据库,评估接受MSA或胃底折叠术的患者。
  • 排除需要Collis胃成形术、食管旁疝修补和急诊病例的患者。
  • 共7882例患者接受MSA(n=597)或胃底折叠术(n=7285)。

主要发现

  • MSA患者更年轻(51 vs 57,p < 0.001),男性比例更高(49.6 vs 34.3%,p < 0.001)。
  • MSA组再手术率与胃底折叠术组相似(1.0 vs 2.0%,p = 0.095)。
  • MSA组再入院率更低(2.2 vs 4.7%,p = 0.005),并发症更少(0.6 vs 4.0%,p < 0.001)。
  • MSA组平均(SD)住院时间更短(0.4 ± 4.3天 vs 1.8 ± 4.6天,p < 0.001),手术时间更短(80.8 ± 36.1分钟 vs 118.7 ± 63.7分钟,p < 0.001)。
  • 两组死亡率相似(0 vs 0.3%,p = 0.175)。

关键数值与推荐

  • 多因素分析显示,MSA与术后并发症减少独立相关(OR 0.23,CI 0.08至0.61,p = 0.002)。
  • 多因素分析显示,MSA与再入院减少独立相关(OR 0.53,CI 0.30至0.94,p = 0.02)。
  • 多因素分析显示,MSA与手术时间缩短独立相关(RC -36.56,CI -41.62至-31.49,p < 0.001)。
  • 多因素分析显示,MSA与住院时间缩短独立相关(RC -1.22,CI -1.61至-0.84,p < 0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Magnetic Sphincter Augmentation (MSA) is an FDA-approved anti-reflux procedure with comparable outcomes to fundoplication. However, most data regarding its use are limited to single or small multicenter studies which may limit the generalizability of its efficacy. The purpose of this study is to evaluate the outcomes of patients undergoing MSA vs fundoplication in a national database. MATERIALS AND METHODS: The 2017-2020 American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) Registry was utilized to evaluate patients undergoing MSA or fundoplication. Patients requiring Collis gastroplasty, paraesophageal hernia repair, and emergency cases, were excluded. Patient outcomes included overall complication rates, readmissions, reoperations, and mortality. RESULTS: A total of 7,882 patients underwent MSA (n = 597) or fundoplication (n = 7285). MSA patients were younger (51 vs 57, p < 0.001), and more often male (49.6 vs 34.3%, p < 0.001). While patients undergoing MSA experienced similar rates of reoperation (1.0 vs 2.0%, p = 0.095), they experienced fewer readmissions (2.2 vs 4.7%, p = 0.005), complications (0.6 vs 4.0%, p < 0.001), shorter mean (SD) hospital length of stay(days) (0.4 ± 4.3 vs 1.8 ± 4.6, p < 0.001) and operative time(min) (80.8 ± 36.1 vs 118.7 ± 63.7, p < 0.001). Mortality was similar between groups (0 vs 0.3%, p = 0.175). On multivariable analysis, MSA was independently associated with reduced postoperative complications (OR 0.23, CI 0.08 to 0.61, p = 0.002), readmissions (OR 0.53, CI 0.30 to 0.94, p = 0.02), operative time (RC - 36.56, CI - 41.62 to - 31.49. p < 0.001) and length of stay (RC - 1.22, CI - 1.61 to - 0.84 p < 0.001). CONCLUSION: In this national database study, compared to fundoplication MSA was associated with reduced postoperative complications, fewer readmissions, and shorter operative time and hospital length of stay. While randomized trials are lacking between MSA and fundoplication, both institutional and national database studies continue to support the use of MSA as a safe anti-reflux operation.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Wisniowski P, Putnam LR, Gallagher S, et al. Short term safety of magnetic sphincter augmentation vs minimally invasive fundoplication: an ACS-NSQIP analysis. Surg Endosc. 2024. PMID: 38334778. doi:10.1007/s00464-024-10672-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。